Treatment of respiratory syncytial virus infections in children

Annals of Medicine

Volumn 26, Issue 5, 1994, Pages 341-343

  Mäkelä, Mika J ^a   Ruuskanen, Olli ^a   Ogra, Pearay L ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Respiratory syncytial virus; Treatment of RSV infection

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; RIBAVIRIN;

BACTERIAL INFECTION; BRONCHIOLITIS; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; HUMAN; IMMUNOTHERAPY; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SHORT SURVEY; VIRUS INFECTION;

ADRENAL CORTEX HORMONES; ANTIBIOTICS; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; INFANT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 0027984310     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899409148348     Document Type: Article

References (18)

1. Respiratory syncytial virus
2. Respiratory syncytial virus infection in children
3. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children
4. Respiratory syncytial virus infections in hospitalized Canadian children: regional differences in patient populations and management practises
5. Bronchodilators for bronchiolitis?
6. Oral versus nebulized albuterol in the management of bronchiolitis in Egypt
7. Albuterol delivered via metered-dose inhaler with spacer for outpatient treatment in young children with wheezing
8. Effect of salbutamol on histamine induced bronchoconstriction in healthy infants
9. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis
10. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection
11. A comparison between nebulized turbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age
12. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children
13. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol
14. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice
15. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
16. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections
17. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement
18. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus